Intranasal priming of newborn mice with microbial extracts increases opsonic factors and mature CD11c+ cells in the airway

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 303, Issue 9, 2012, Pages

  Kasahara, Kazuki ^a   Matsumura, Yoko ^a   Ui, Kouji ^a   Kasahara, Kei ^a   Komatsu, Yuko ^a   Mikasa, Keiichi ^a   Kita, Eiji ^a  

^a NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Commensal flora; Regulation of acute inflammation; Surfactants

Indexed keywords

COMPLEMENT COMPONENT C3; GLYCOPROTEIN P 15095; LUNG SURFACTANT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; OPSONIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MICROBIAL EXTRACT; MICROBIOLOGICAL PARAMETERS; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS PNEUMONIAE;

AIR MICROBIOLOGY; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, BACTERIAL; ANTIGENS, CD11C; ANTIGENS, FUNGAL; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; COMPLEMENT C3; CYTOKINES; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNITY, INNATE; INFLAMMATION MEDIATORS; LUMINESCENT AGENTS; LUMINOL; MACROPHAGES, ALVEOLAR; MALE; MANNOSE-BINDING LECTINS; MICE; MICE, INBRED C57BL; NASAL CAVITY; OPSONIN PROTEINS; PHAGOCYTOSIS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RECEPTORS, IMMUNOLOGIC; RESPIRATORY MUCOSA;

EID: 84868383584     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00031.2012     Document Type: Article

References (48)

1. Alexander JE, Berry AM, Paton JC, Rubins JB, Andrew PW, Mitchell TJ. Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia. Microb Pathog 24: 167-174, 1998.
2. Arredouani M, Yang Z, Ning Y, Qin G, Soininen R, Tryggvason K, Kobzik L. The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles. J Exp Med 200: 267-272, 2004.
3. Beisswenger C, Lysenko ES, Weiser JN. Early bacterial colonization induces toll-like receptor-dependent transforming growth factor beta signaling in the epithelium. Infect Immun 77: 2212-2220, 2009.
4. Brown JS, Hussell T, Gilliland SM, Holden DW, Paton JC, Ehrenstein MR, Walport MJ, Botto M. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc Natl Acad Sci USA 99: 16969-16974, 2002.
5. Crouch E, Wright JR. Surfactant proteins A and D and pulmonary host defense. Annu Rev Physiol 63: 521-554, 2001.
6. Dahl M, Bauer AK, Arredouani M, Soininen R, Tryggvason K, Kleeberger SR, Kobzik L. Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II. J Clin Invest 117: 757-764, 2007.
7. Duggan JM, You D, Cleaver JO, Larson DT, Garza RJ, Guzmán Pruneda FA, Tuvim MJ, Zhang J, Dickey BF, Evans SE. Synergistic interactions of TLR2/6 and TLR9 induce a high level of resistance to lung infection in mice. J Immunol 186: 5916-5926, 2011.
8. Emoto M, Yoshida T, Fukuda T, Kawamura I, Mitsuyama M, Kita E, Hurwitz R, Kaufmann SH, Emoto Y.-Galactosylceramide promotes killing of Listeria monocytogenes within the macrophage phagosome through invariant NKT cell activation. Infect Immun 78: 2667-2676, 2010.
9. Gabryszewski SJ, Bachar O, Dyer KD, Percopo CM, Killoran KE, Domachowske JB, Rosenberg HF. Lactobacillus-mediated priming of the respiratory mucosa protects against lethal pneumovirus infection. J Immunol 186: 1151-1161, 2011.
10. Haagsman HP. Interactions of surfactant protein A with pathogens. Biochim Biophys Acta 1408: 264-277, 1998.
11. Haagsman HP, Hogenkamp A, van Eijk M, Veldhuizen EJ. Surfactant collectins and innate immunity. Neonatology 93: 288-294, 2008.
12. Hartshorn KL, Crouch E, White MR, Colamussi ML, Kakkanatt A, Tauber B, Shepherd V, Sastry KN. Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am J Physiol Lung Cell Mol Physiol 274: L958-L969, 1998.
13. Higashi N, Matsumura Y, Mizuno F, Kasahara K, Sugiura S, Mikasa K, Kita E. Enhanced expression of ATP-binding cassette transporter A1 in non-rafts decreases the sensitivity of vascular endothelial cells to Shiga toxin. Microb Pathog 49: 141-152, 2010.
14. Hooper LV, Wong MH, Thelin A, Hansson L, Falk PG, Gordon JI. Molecular analysis of commensal host-microbial relationships in the intestine. Science 291: 881-884, 2001.
15. Jounblat R, Clark H, Eggleton P, Hawgood S, Andrew PW, Kadioglu A. The role of surfactant protein D in the colonisation of the respiratory tract and onset of bacteraemia during pneumococcal pneumonia. Respir Res 6: 126, 2005.
16. Kadioglu A, Andrew AW. The innate immune response to pneumococcal lung infection: the untold story. Trends Immunol 25: 143-149, 2004.
17. Kelly D, King T, Aminov R. Importance of microbial colonization of the gut in early life to the development of immunity. Mutat Res 622: 58-69, 2007.
18. Kerr AR, Paterson GK, Riboldi-Tunnicliffe A, Mitchell TJ. Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3. Infect Immun 73: 4245-4252, 2005.
19. Kuroki Y, Takahashi M, Nishitani C. Pulmonary collectins in innate immunity of the lung. Cell Microbiol 9: 1871-1879, 2007.
20. Kuronuma K, Sano H, Kato K, Kudo K, Hyakushima N, Yokota S, Takahashi H, Fujii N, Suzuki H, Kodama T, Abe S, Kuroki Y. Pulmonary surfactant protein A augments the phagocytosis of Streptococcus pneumoniae by alveolar macrophages through a casein kinase 2-dependent increase of cell surface localization of scavenger receptor A. J Biol Chem 279: 21421-21430, 2004.
21. LeBouder E, Rey-Nores JE, Raby AC, Affolter M, Vidal K, Thornton CA, Labéta MO. Modulation of neonatal microbial recognition: TLRmediated innate immune responses are specifically and differentially modulated by human milk. J Immunol 176: 3742-3752, 2006.
22. Lefokowitz SS, Gelderman MP, Lefokowitz DL, Moguilevsky N, Bollen A. Phagocytosis and intracellular killing of Candida albicans by macrophages exposed to myeloperoxidase. J Infect Dis 173: 1202-1207, 1996.
23. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 7: 379-390, 2007.
24. Li J, Glover DT, Szalai AJ, Hollingshead SK, Briles DE. PspA and PspC minimize immune adherence and transfer of pneumococci from erythrocytes to macrophages through their effects on complement activation. Infect Immun 75: 5877-5885, 2007.
25. Liu X, Wetzler LM, Nascimento LO, Massari P. Human airway epithelial cell responses to Neisseria lactamica and purified porin via Toll-like receptor 2-dependent signaling. Infect Immun 7853: 5314-5323, 2010.
26. Mann JR, Simpson JS, Munkley RM, Stuart J. Lysosomal enzyme cytochemistry in acute leukaemia. J Clin Pathol 24: 831-836, 1971.
27. Maródi L. Neonatal innate immunity to infectious agents. Infect Immun 74: 1999-2006, 2006.
28. Mayer AK, Dalpke AH. Regulation of local immunity by airway epithelial cells. Arch Immunol Ther Exp (Warsz) 55: 353-362, 2007.
29. Mellor AL, Sivakumar J, Chandler P, Smith K, Molina H, Mao D, Munn DH. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2: 64-68, 2001.
30. Munn DH, Sharma MD, Lee JR, Jhaver KG, Johnson TS, Keskin DB, Marshall B, Chandler P, Antonia SJ, Burgess R, Slingluff CL Jr, Mellor AL. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 297: 1867-1870, 2002.
31. Murakami S, Iwaki D, Mitsuzawa H, Sano H, Takahashi H, Voelker DR, Akino T, Kuroki Y. Surfactant protein A inhibits peptidoglycaninduced tumor necrosis factor-alpha secretion in U937 cells and alveolar macrophages by direct interaction with toll-like receptor 2. J Biol Chem 277: 6830-6837, 2002.
32. Neth O, Jack DL, Dodds AW, Holzel H, Klein NJ, Turner MW. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect Immun 68: 688-693, 2000.
33. r mice requires C3 activation by Salmonella lipopolysaccharide. Immunology 95: 640-647, 1998.
34. Ohya M, Nishitani C, Sano H, Yamada C, Mitsuzawa H, Shimizu T, Saito T, Smith K, Crouch E, Kuroki Y. Human pulmonary surfactant protein D binds the extracellular domains of Toll-like receptors 2 and 4 through the carbohydrate recognition domain by a mechanism different from its binding to phosphatidylinositol and lipopolysaccharide. Biochemistry 45: 657-664, 2006.
35. Pastva AM, Wright JR, Williams KL. Immunomodulatory roles of surfactant proteins A and D: implications in lung disease. Proc Am Thorac Soc 4: 252-257, 2007.
36. PrabhuDas M, Adkins B, Gans H, King C, Levy O, Ramilo O, Siegrist CA. Challenges in infant immunity: implications for responses to infection and vaccines. Nat Immunol 12: 189-194, 2011.
37. Quin LR, Moore QC 3rd, McDaniel LS. Pneumolysin, PspA, and PspC contribute to pneumococcal evasion of early innate immune responses during bacteremia in mice. Infect Immun 75: 2067-2070, 2007.
38. Renz H, Brandtzaeg P, Hornef M. The impact of perinatal immune development on mucosal homeostasis and chronic inflammation. Nat Rev Immunol 12: 9-23, 2011.
39. Rook GA, Brunet LR. Microbes, immunoregulation, and the gut. Gut 54: 317-320, 2005.
40. Round JL, Lee SM, Li J, Tran G, Jabri B, Chatila TA, Mazmanian SK. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332: 974-977, 2011.
41. Steinman R. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9: 271, 1991.
42. Takabayashi T, Vannier E, Clark BD, Margolis NH, Dinarello CA, Burke JF, Gelfand JA. A new biologic role for C3a and C3a desArg. J Immunol 156: 3455-3460, 1996.
43. Takahashi K, Gordon J, Liu H, Sastry KN, Epstein JE, Motwani M, Laursen I, Thiel S, Jensenius JC, Carroll M, Ezekowitz RA. Lack of mannose-binding lectin-A enhances survival in a mouse model of acute septic peritonitis. Microbes Infect 4: 773-784, 2002.
44. Vollaard EJ, Clasener HA. Colonization resistance. Antimicrob Agents Chemother 38: 409-414, 1994.
45. van der Waaij D, Berghuis-de Vries JM, Lekkerkerk-van der Wees JEC. Colonization resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg (Lond) 69: 405-411, 1971.
46. Yamada C, Sano H, Shimizu T, Mitsuzawa H, Nishitani C, Himi T, Kuroki Y. Surfactant protein A directly interacts with TLR4 and MD-2 and regulates inflammatory cellular response: importance of supratrimeric oligomerization. J Biol Chem 281: 21771-21780, 2006.
47. Yasuda Y, Kasahara K, Mizuno F, Nishi K, Mikasa K, Kita E. Roxithromycin favourably modifies the initial phase of resistance against infection with macrolide-resistant Streptococcus pneumoniae in a murine pneumonia model. Antimicrob Agents Chemother 51: 1741-1752, 2007.
48. Yasuda Y, Matsumura Y, Kasahara K, Ouji N, Sugiura S, Mikasa K, Kita E. Microbial exposure early in life regulates airway inflammation in mice after infection with Streptococcus pneumoniae with enhancement of local resistance. Am J Physiol Lung Cell Mol Physiol 298: L67-L78, 2010.